Special Drug Use Survey for Long-term Use of JOYCLU 30mg Intra-articular Injection in Patients with Osteoarthritis

Special Drug Use Survey for Long-term Use of JOYCLU 30mg Intra-articular Injection in Patients with Osteoarthritis - Special Drug Use Survey for Long-term Use of JOYCLU 30mg Intra-articular Injection in Patients with Osteoarthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046772

Enrollment

750

Registered

2022-01-31

Start date

2022-02-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis (knee joint and hip joint)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: JOYCLU naive patients with osteoarthritis (knee joint and hip joint)

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Safety - Occurrence of adverse events and adverse reactions - Occurrence of mulfunctions Efficacy - Changes from baseline of pain in osteoarthritis (knee joint and hip joint) - Physician global evaluation	—

Countries

Japan

Contacts

Public ContactHiroyuki Hosokawa

SEIKAGAKU CORPORATION Pharmacovigilance Dept.

JCL_GPSP_SKK@seikagaku.co.jp03-5220-8556

Outcome results